Full Description
The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD).
Covering the major issues dominating the field, this book offers a broad vision on NAFLD using key data for a deep and thorough understanding of the latest diagnostic methods, treatment options, potential complications, and disease management strategies to improve patient outcomes.
The volume bridges the trans-disciplinary divide between hepatologists, cardiologists, nephrologists, psychiatrists, oncologists and dermatologists in order to cover the complex management of NAFLD in a single volume.
It operates under a modern definition of NAFLD that acknowledges the range of presentations related to extrahepatic complications that hepatologists see in daily practice, while also delving into unanswered questions and future directions regarding treatment options.
Offering practical, clinical guidance in addition to capturing the new promising therapeutic approaches in the pipeline, this book is an essential reference for clinicians, researchers and students.
Contents
Chapter 1: The nomenclature and definition of nonalcoholic fatty liver disease.- Chapter 2: Nonalcoholic fatty liver disease versus metabolic associated fatty liver disease.- Chapter 3: Natural history of nonalcoholic fatty liver disease.- Chapter 4: Hepatocellular carcinoma in nonalcoholic fatty liver disease.- Chapter 5: Genetics and epigenetics in nonalcoholic fatty liver disease.- Chapter 6: The place of transabdominal liver biopsy in nonalcoholic fatty liver disease.- Chapter 7: Alternative methods for liver biopsy - endoscopic ultrasound-guided and transjugular liver biopsy- endoscopic ultrasound-guided and transjugular liver biopsy.- Chapter 8: Morphopathology of nonalcoholic fatty liver disease.- Chapter 9: 2D shear wave elastography performance in the diagnosis of nonalcoholic fatty liver disease.- Chapter 10: Vibration controlled transient elastography and controlled attenuation parameter for staging nonalcoholic fatty liver disease.- Chapter 11: The value ofserologic markers/scores in the assessment of nonalcoholic fatty liver disease.- Chapter 12: Nonalcoholic fatty liver disease within other causes of chronic liver diseases.-Chapter 13: Pathophisiology and risk stratification in cardiovascular diseases and NAFLD.- Chapter 14: Type 2 diabetes mellitus and insulin resistance in nonalcoholic fatty liver disease.- Chapter 15: Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease.- Chapter 16: Endocrinopathies in nonalcoholic fatty liver disease.- Chapter 17: Nonalcoholic Fatty liver disease and extraheoatic malignancies.- Chapter 18: Psychological burden of NAFLD and psychiatric disorders as extrahepatic manifestations.- Chapter 19: Obstructive sleep apnea syndrome and nonalcoholic fatty liver disease.- Chapter 20: Nonalcoholic fatty liver disease and psoriasis.- Chapter 21: Current management and pipeline treatment approaches in NAFLD - summary of ongoing RCTs and future directions.- Chapter 22: Practical clinical cases in nonalcoholic fatty liver disease.
